课题基金 / 基金详情

7th International Conference on Clinical Cancer Prevention 2012 with Consensus Co

7th International Conference on Clinical Cancer Prevention 2012 with Consensus Co
2012 年第七届临床癌症预防国际会议与共识公司
批准号:
8400378
负责人:
FRANK L. MEYSKENS
金额:
$2.0万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-03-01 至 2014-02-28

项目摘要

项目成果

FRANK L. MEYSKENS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):国际癌症预防学会是一个非营利性组织,成立于1995年,其使命是为癌症预防研究和发展提供一个国际论坛,促进实验室、流行病学和临床研究人员在癌症预防方面的互动,并开展教育活动,以增进专业和公众对癌症预防的了解。到目前为止,ISCaP已经组织了6次两年一次的临床癌症预防会议,特别侧重于弥合模式系统中以实验室为基础的预防活动与大型临床项目之间的差距,例如更注重公共卫生的主要预防试验。第七次两年期会议将于2012年9月24日至26日在联合王国伦敦举行。这次会议的目的是审查关于目前预防主要癌症的选择的证据,促进科学家在癌症预防领域的互动,刺激 研究合作,并将正在接受培训的科学家和临床医生引入该领域。它将评估目前与前列腺癌化学预防有关的证据,并起草一份关于研究和实践建议的共识声明。会议将在无烟和完全无障碍的会议设施中举行,会场将提供托儿设施。为期3天的会议将包括独立演讲、小组讨论、初级研究人员互动会议和共识发展会议。来自不同学科的约40名演讲者被挑选出来,因为他们在各自领域被公认为是该领域的领导者,他们的工作与癌症预防相关,他们将涵盖从致癌机制、生物标记物、分子靶标、传染性致癌物、各种预防疗法到实施和政策问题的广泛主题。会议将通过各种途径广泛宣传,并将在会议前几个月征求摘要,将选出30篇排名最高的摘要用于演示,6篇作为口头摘要,24篇作为海报。专门计划了一次互动会议,以刺激和吸引初级研究人员到该领域来,4名初级研究人员也将获得补充注册,其他人将被收取折扣注册费。我们预计约有250名代表将参加本次会议,为了吸引妇女、代表人数不足的少数群体和残疾代表,还将颁发6个补充登记。将获得欧洲范围的继续医学教育认证;这些学分也得到了美国医学会的认可。鉴于此次会议所需资源有限,且所需费用可观,我们请求NCI提供资金支持,这些资金将专门用于支付美国教师的部分旅费。会议将把来自世界各地的癌症预防研究人员聚集在一个有利和互动的环境中,促进科学对话和思想交流,并吸引年轻人到该领域进一步开展癌症预防研究。
英文摘要
DESCRIPTION (provided by applicant): ISCaP, the International Society for Cancer Prevention is a non-profit organization founded in 1995 with a mission to provide an international forum for research and development in cancer prevention, promote interaction among laboratory, epidemiological and clinical researchers in cancer prevention and conduct educational activities to enhance professional and public understanding of cancer prevention. ISCaP has so far organized 6 biennial Clinical Cancer Prevention meetings with special focus on bridging the gap between laboratory-based prevention activities in model systems and large scale clinical projects, such as the major prevention trials which have a more public health focus. The 7th biennial meeting will be held in London, United Kingdom from 24th to 26th September 2012. This meeting aims to review evidence on current options for prevention of major cancers, facilitate interaction among scientists in the field of cancer prevention, stimulate research collaborations, and introduce in-training scientists and clinicians to the field. It will lso evaluate current evidence relating to chemoprevention of prostate cancer and draft a consensus statement on recommendations for research and practice. The meeting will be held at smoke-free and fully- accessible conference facilities, childcare facilities will be provided at the venu. The meeting spread over 3 days will comprise of standalone presentations, panel discussions, interactive session for junior researchers and consensus development session. About 40 speakers from diverse disciplines have been chosen on the basis that they are widely acknowledged as leader in their field and their work is relevant to cancer prevention and they will cover wide-ranging topics from carcinogenesis, biomarkers, molecular targets, infectious carcinogens, various preventive therapies to implementation and policy issues. Meeting will be widely publicized through various routes and abstracts will be solicited several months prior to the meeting, 30 top-ranked abstracts will be selected for presentation, 6 as oral and 24 as poster. An interactive session has been specially planned to stimulate and attract junior researchers to the field, and 4 junior researchers will also receive complementary registrations, others will be charged discounted registration fees. We anticipate that approximately 250 delegates will participate in this meeting and to attract women, underrepresented minority and disabled delegates, 6 more complementary registrations will be awarded. Europe-wide CME accreditation will be obtained; these credits are also recognized by the American Medical Association. In view of limited resources and considerable expenses required for the meeting we request funding support from NCI, these funds will specifically be used to partially cover travel costs of US-based faculty. The meeting will bring together cancer prevention researchers from all over world in a conducive and interactive environment that will promote scientific dialogue and exchange of ideas and attract young minds to the field to further cancer prevention research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The 19th Annual Meeting of the Pan American Society for Pigment Cell Research Conference
  • 批准号:
    8986392
  • 项目类别:
  • 资助金额:
    $2.5万
  • 财政年份:
    2015
  • 负责人:
    FRANK L. MEYSKENS
  • 依托单位:
PROTOCOL SPECIFIC RESEARCH SUPPORT
  • 批准号:
    7944582
  • 项目类别:
  • 资助金额:
    $4.78万
  • 财政年份:
    2009
  • 负责人:
    FRANK L. MEYSKENS
  • 依托单位:
DEVELOPMENT FUNDS
  • 批准号:
    7944501
  • 项目类别:
  • 资助金额:
    $25.5万
  • 财政年份:
    2009
  • 负责人:
    FRANK L. MEYSKENS
  • 依托单位:
STRUCTURAL MOLECULAR BIOLOGY PROGRAM
  • 批准号:
    7944517
  • 项目类别:
  • 资助金额:
    $1.49万
  • 财政年份:
    2009
  • 负责人:
    FRANK L. MEYSKENS
  • 依托单位:
海外基金